U.S., June 5 -- ClinicalTrials.gov registry received information related to the study (NCT07627074) titled 'Weight Loss in Adults Using Semaglutide (Real-world Study)' on May 30.
Brief Summary: The purpose of the study is to assess the weight loss in participants treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician.
Study Start Date: May 12
Study Type: OBSERVATIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: Semaglutide
This is a retrospective, non-interventional study; therefore, no intervention was administered as part of the study.
Recruitment Status: RECRUITING
Sponsor: Novo Nordisk A/S
Published by HT Digital Content Services with permission...